News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
AbbVie and Ripple collaborate to develop sustainable drug delivery implants for glaucoma treatment leveraging expertise and innovative technology